Quantum BioPharma Soars 12.09% on Anti-Manipulation Moves

On March 27, 2025, Quantum BioPharma's stock rose 12.09 in pre-market trading.

Quantum BioPharma has made significant strides in combating naked short selling and stock manipulation by appointing Terry Lynch to its board of directors. Lynch is renowned for his leadership in Save Canadian Mining, a non-profit organization dedicated to fighting against micro-cap stock manipulation. This move is expected to bolster investor confidence and potentially stabilize the company's stock price.

Additionally, the company has taken steps to address internal governance by replacing Dr. Sanjiv Chopra, who resigned from the board. This change is part of Quantum BioPharma's ongoing efforts to strengthen its leadership and operational efficiency, which could positively impact its market performance.